In a randomised crossover study of 10 people with type 2 diabetes, blocking the GIP receptor with GIP(3-30)NH2 during oral glucose lowered the glucose-induced rise in superior mesenteric artery blood flow (57% rise; 15% lower with antagonist, p=0.012) versus saline.
RCTn = 10
Rasmussen et al. GIP contributes to postprandial regulation of splanchnic blood supply in humans with type 2 diabetes: a randomised, single-blinded, placebo-controlled, crossover study